Condition

Long QT Syndrome Type 3 (2)

Overall Status

Terminated (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Gilead Sciences (1)

Tel-Aviv Sourasky Medical Center (1)

Collaborator

Intervention

eleclazine (1)

eleclazine placebo (1)

ranolazine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

long qt syndrome type 3

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Long QT Syndrome Type 3 Trial in Worldwide (Eleclazine, Eleclazine )

Terminated

Long QT Syndrome Type 3

Eleclazine
Eleclazine placebo

Rochester, Minnesota
+11 more

Dec 12, 2017

Long QT Syndrome Type 3 Trial in Tel Aviv (Ranolazine)

Unknown status

Long QT Syndrome Type 3

Ranolazine

Tel Aviv, Israel

Tel Aviv Medical Center

Mar 25, 2015